{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T11:55:00Z","timestamp":1726228500510},"reference-count":63,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["seminoncol.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1053\/j.seminoncol.2016.08.008","type":"journal-article","created":{"date-parts":[[2016,9,21]],"date-time":"2016-09-21T20:22:59Z","timestamp":1474489379000},"page":"609-614","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Strategies for clinical implementation of screening for hereditary cancer syndromes"],"prefix":"10.1053","volume":"43","author":[{"given":"Brandie","family":"Heald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Marquard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Funchain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/j.seminoncol.2016.08.008_bib1","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1200\/JCO.2013.50.9257","article-title":"American Society of Clinical Oncology Expert Statement: collection and use of a cancer family history for oncology providers","volume":"32","author":"Lu","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib2","unstructured":"Genetic\/Familial High-Risk Assessment: Breast and Ovarian. 2015. (Accessed January 23, 2016, at www.nccn.org.)"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib3","unstructured":"Genetic\/Familial High-Risk Assessment: Colorectal. 2015. (Accessed January 23, 2016, at www.nccn.org.)"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib4","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1093\/jnci\/djr114","article-title":"Confirmation of family cancer history reported in a population-based survey","volume":"103","author":"Mai","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib5","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.1002\/cncr.26166","article-title":"Reported referral for genetic counseling or BRCA 1\/2 testing among United States physicians: a vignette-based study","volume":"117","author":"Trivers","year":"2011","journal-title":"Cancer"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.ygyno.2012.03.025","article-title":"A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk","volume":"125","author":"Vogel","year":"2012","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib7","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1200\/JCO.1996.14.5.1730","article-title":"genetic testing for cancer susceptibility, Adopted on February 20, 1996","volume":"14","year":"1996","journal-title":"J Clin Oncol"},{"issue":"Suppl 1","key":"10.1053\/j.seminoncol.2016.08.008_bib8","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1111\/j.1524-4741.2004.101S4.x","article-title":"Risk modeling in breast cancer","volume":"10","author":"Euhus","year":"2004","journal-title":"Breast J"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1038\/ajg.2014.186","article-title":"Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-society Task Force on colorectal cancer","volume":"109","author":"Giardiello","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib10","first-page":"108","article-title":"Comparison of prediction models for Lynch syndrome among individuals with colorectal cancer","author":"Kastrinos","year":"2016","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/GIM.0b013e31818efd9d","article-title":"Recommendations from the EGAPP Working Group: can UGT1A1 genotyping reduce morbidity and mortality in patients with metastatic colorectal cancer treated with irinotecan?","volume":"11","year":"2009","journal-title":"Genet Med"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib12","unstructured":"Genomics. 2016. (Accessed January 27, 2016, at http:\/\/www.healthypeople.gov\/2020\/topics-objectives\/topic\/genomics)"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib13","unstructured":"SGO Clinical Practice Statement: Screening for Lynch syndrome in endometrial cancer. 2014. (Accessed January 27, 2016, at https:\/\/www.sgo.org\/clinical-practice\/guidelines\/screening-for-lynch-syndrome-in-endometrial-cancer\/.)"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/gim.2014.31","article-title":"Comparing universal Lynch syndrome tumor-screening programs to evaluate associations between implementation strategies and patient follow-through","volume":"16","author":"Cragun","year":"2014","journal-title":"Genet Med"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10689-013-9611-5","article-title":"How do we approach the goal of identifying everybody with Lynch syndrome?","volume":"12","author":"Hampel","year":"2013","journal-title":"Fam Cancer"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1200\/JCO.2012.45.1674","article-title":"Implementation of universal microsatellite instability and immunohistochemistry screening for diagnosing lynch syndrome in a large academic medical center","volume":"31","author":"Heald","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2013.04.022","article-title":"Implementation of tumor testing for lynch syndrome in endometrial cancers at a large academic medical center","volume":"130","author":"Moline","year":"2013","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib18","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10897-011-9462-x","article-title":"Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors","volume":"21","author":"Riley","year":"2012","journal-title":"J Genet Couns"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/gim.2013.166","article-title":"ACMG technical standards and guidelines for genetic testing for inherited colorectal cancer (Lynch syndrome, familial adenomatous polyposis, and MYH-associated polyposis)","volume":"16","author":"Hegde","year":"2014","journal-title":"Genet Med"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib20","first-page":"271","article-title":"Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement","volume":"160","author":"Moyer","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib21","unstructured":"SGO Clinical Practice Statement: Genetic testing for ovarian cancer. 2014. (Accessed January 27, 2016, at https:\/\/www.sgo.org\/clinical-practice\/guidelines\/genetic-testing-for-ovarian-cancer\/.)"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib22","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.6004\/jnccn.2014.0128","article-title":"Gene panel testing for inherited cancer risk","volume":"12","author":"Hall","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12885-015-1224-y","article-title":"Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk","volume":"15","author":"Judkins","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib24","article-title":"The integration of next-generation sequencing panels in the clinical cancer genetics practice: an institutional experience","author":"Mauer","year":"2013","journal-title":"Genet Med"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.jmoldx.2012.03.002","article-title":"ColoSeq provides comprehensive lynch and polyposis syndrome mutational analysis using massively parallel sequencing","volume":"14","author":"Pritchard","year":"2012","journal-title":"J Mol Diagn"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib26","series-title":"Germline mutations identified by a 25 gene panel in patients undergoing Lynch syndrome testing","author":"Yurgelun","year":"2013"},{"issue":"604-13","key":"10.1053\/j.seminoncol.2016.08.008_bib27","first-page":"e20","article-title":"Identification of a variety of mutations in cancer predisposition genes in patients with suspected Lynch syndrome","volume":"149","author":"Yurgelun","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib28","unstructured":"SGO Clinical Practic Statement: Next generation cancer gene panels versus gene by gene testing. 2014. (Accessed January 27, 2016, at https:\/\/www.sgo.org\/clinical-practice\/guidelines\/next-generation-cancer-gene-panels-versus-gene-by-gene-testing\/.)"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib29","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1200\/JCO.2015.63.0996","article-title":"American Society of Clinical Oncology policy statement update: genetic and genomic testing for cancer susceptibility","volume":"33","author":"Robson","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib30","year":"2012","journal-title":"Cancer program standards 2012: ensuring patient-centered care"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib31","article-title":"Germline variants in cancer risk genes detected by NGS-based comprehensive tumor genomic profiling (CGP)","author":"Hall","year":"2015","journal-title":"Poster presented at: Annual Meeting of the American Society of Clinical Oncology Chicago, IL"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib32","article-title":"Prevalence of incidental actionable germline mutations in 1,000 advanced cancer patients on a prospective somatic genomic profiling program","author":"Meric-Bernstam","year":"2015","journal-title":"Poster presented at: Annual Meeting of the American Society of Clinical Oncology. Chicago, IL"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib33","article-title":"Tumor relevant germline findings in targeted tumor sequencing using matched normal DNA of 1,570 unselected cases","author":"Schrader","year":"2015","journal-title":"Paper presented at: Annual Meeting of the American Society of Clinical Oncology. Chicago, IL"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib34","article-title":"Hereditary implications of somatic tumor testing","author":"Funchain","year":"2015","journal-title":"Poster presented at: Annual Meeting of the American Society of Clinical Oncology. Chicago, IL"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib35","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1634\/theoncologist.2013-0405","article-title":"Molecular tumor board: the University of California-San Diego Moores Cancer Center experience","volume":"19","author":"Schwaederle","year":"2014","journal-title":"Oncologist"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib36","first-page":"108","article-title":"Prospective clinical study of precision oncology in solid tumors","author":"Sohal","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib37","doi-asserted-by":"crossref","first-page":"3342","DOI":"10.1245\/s10434-014-3921-1","article-title":"Implementing a screening tool for identifying patients at risk for hereditary breast and ovarian cancer: a statewide initiative","volume":"21","author":"Brannon Traxler","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib38","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1086\/301670","article-title":"Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2","volume":"62","author":"Parmigiani","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib39","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1200\/JCO.2002.20.2.528","article-title":"Identification and referral of families at high risk for cancer susceptibility","volume":"20","author":"Sweet","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000294415","article-title":"Health Heritage(c) a web-based tool for the collection and assessment of family health history: initial user experience and analytic validity","volume":"13","author":"Cohn","year":"2010","journal-title":"Public Health Genomics"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib41","unstructured":"http:\/\/www.hughesriskapps.com\/. Last accessed 09\/29\/2016."},{"key":"10.1053\/j.seminoncol.2016.08.008_bib42","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/GIM.0b013e3181e15bd5","article-title":"Validation of My Family Health Portrait for six common heritable conditions","volume":"12","author":"Facio","year":"2010","journal-title":"Genet Med"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.18043\/ncm.74.4.287","article-title":"Development and validation of a primary care-based family health history and decision support program (MeTree)","volume":"74","author":"Orlando","year":"2013","journal-title":"N Carolina Med J"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib44","unstructured":"Information Technology Tools. 2013. (Accessed January 26, 2016, at http:\/\/nsgc.org\/p\/do\/si\/topic=57.)"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib45","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ygyno.2011.01.020","article-title":"Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer","volume":"121","author":"Zhang","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib46","doi-asserted-by":"crossref","first-page":"18032","DOI":"10.1073\/pnas.1115052108","article-title":"Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing","volume":"108","author":"Walsh","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib47","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1038\/bjc.2012.452","article-title":"Frequency of mutations in mismatch repair genes in a population-based study of women with ovarian cancer","volume":"107","author":"Pal","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib48","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1200\/JCO.2015.61.2408","article-title":"Contribution of germline mutations in the RAD51B, RAD51C, and RAD51D genes to ovarian cancer in the population","volume":"33","author":"Song","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib49","first-page":"107","article-title":"Germline mutations in the BRIP1, BARD1, PALB2, and NBN genes in women with ovarian cancer","author":"Ramus","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib50","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s10549-012-2348-2","article-title":"Evaluation of BRCA1 mutations in an unselected patient population with triple-negative breast cancer","volume":"137","author":"Rummel","year":"2013","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2407-9-86","article-title":"The prevalence of BRCA1 mutations among young women with triple-negative breast cancer","volume":"9","author":"Young","year":"2009","journal-title":"BMC Cancer"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib52","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1158\/1078-0432.CCR-10-2560","article-title":"Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer","volume":"17","author":"Gonzalez-Angulo","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib53","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1136\/jmedgenet-2011-100006","article-title":"Prevalence of BRCA1 and BRCA2 mutations in triple negative breast cancer","volume":"48","author":"Evans","year":"2011","journal-title":"J Med Genet"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib54","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s10549-010-1195-2","article-title":"Mutations in BRCA2 and PALB2 in male breast cancer cases from the United States","volume":"126","author":"Ding","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib55","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.gastro.2015.06.003","article-title":"Accuracy of hereditary diffuse gastric cancer testing criteria and outcomes in patients with a germline mutation in CDH1","volume":"149","author":"van der Post","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1001\/jamaoncol.2014.168","article-title":"Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond","volume":"1","author":"Hansford","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib57","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1200\/JCO.2013.52.6863","article-title":"Prevalence and functional consequence of TP53 mutations in pediatric adrenocortical carcinoma: a Children\u05f3s Oncology Group study","volume":"33","author":"Wasserman","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib58","doi-asserted-by":"crossref","first-page":"E476","DOI":"10.1210\/jc.2011-1982","article-title":"TP53 germline mutations in adult patients with adrenocortical carcinoma","volume":"97","author":"Herrmann","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib59","doi-asserted-by":"crossref","first-page":"E119","DOI":"10.1210\/jc.2012-2198","article-title":"Prevalence of germline TP53 mutations in a prospective series of unselected patients with adrenocortical carcinoma","volume":"98","author":"Raymond","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib60","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1200\/JCO.2012.48.0988","article-title":"Adrenocortical carcinoma is a lynch syndrome-associated cancer","volume":"31","author":"Raymond","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib61","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1227\/01.NEU.0000159646.15026.D6","article-title":"Hemangioblastomas of central nervous system: molecular genetic analysis and clinical management","volume":"56","author":"Catapano","year":"2005","journal-title":"Neurosurgery"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib62","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/cen.12686","article-title":"Twenty years of lesson learning: how does the RET genetic screening test impact the clinical management of medullary thyroid cancer?","volume":"82","author":"Romei","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1053\/j.seminoncol.2016.08.008_bib63","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/cen.12530","article-title":"Testing for germline mutations in sporadic pheochromocytoma\/paraganglioma: a systematic review","volume":"82","author":"Brito","year":"2015","journal-title":"Clin Endocrinol"}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416300410?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775416300410?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T23:24:37Z","timestamp":1657322677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775416300410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":63,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0093775416300410"],"URL":"https:\/\/doi.org\/10.1053\/j.seminoncol.2016.08.008","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strategies for clinical implementation of screening for hereditary cancer syndromes","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.seminoncol.2016.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}